Published in Medical Letter on the CDC and FDA, August 30th, 1999
For patients infected with these drug-resistant organisms, there are few, if any, therapeutic options.
Now, a study by researchers at Northwestern University Medical School and Northwestern Memorial Hospital reports that linezolid, a new antibiotic, is highly effective against a range of Gram-positive bacteria, including several antibiotic-resistant enterococci and staphylococci.
The study, which appeared in the August 1999 issue of Antimicrobial Agents and Chemotherapy, described the largest...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.